By taking advantage of our first mover opportunities our goal is to maximize shareholders value over time.
Through continuous innovation and deployment of our products and solutions designed for this industry, we aim to become a leading provider of turn-key solutions in a market which continues to show strong growth rates.
CellCura’s ability to create value is dependent on applying high ethical standards in all aspects of our business. CellCura believes that sufficient, objective and timely information to the market is imperative irrespective of whether the information is positive or negative. Such information will be disclosed simultaneously and on an equal basis to shareholders, analysts and other market players. All shareholders will be treated equally no matter their shareholding or connection to the company.
Extraordinary General Meeting 10 Januar, 2012
Minutes of meeting
Protokoll
Summons to extraordinary general meeting
Innkalling til ekstraordinær generalforsamling
Statement
Extraordinary General Meeting 3 November, 2011
Minutes of meeting
Protokoll
Summons to extraordinary general meeting
Innkalling til ekstraordinær generalforsamling
Annual General Meeting 17 June, 2011
Summons to ordinary general meeting
Innkalling til ordinær generalforsamling
Valgkomiteens innstilling
Annual Report 2010